FI102382B1 - Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten - Google Patents
Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja vartenInfo
- Publication number
- FI102382B1 FI102382B1 FI903154A FI903154A FI102382B1 FI 102382 B1 FI102382 B1 FI 102382B1 FI 903154 A FI903154 A FI 903154A FI 903154 A FI903154 A FI 903154A FI 102382 B1 FI102382 B1 FI 102382B1
- Authority
- FI
- Finland
- Prior art keywords
- glycoproteins
- respiratory syncytial
- syncytial virus
- human respiratory
- expression system
- Prior art date
Links
- 102000003886 Glycoproteins Human genes 0.000 title abstract 5
- 108090000288 Glycoproteins Proteins 0.000 title abstract 5
- 241000711920 Human orthopneumovirus Species 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000011081 inoculation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13738787A | 1987-12-23 | 1987-12-23 | |
| US13738787 | 1987-12-23 | ||
| PCT/US1988/003784 WO1989005823A1 (en) | 1987-12-23 | 1988-10-31 | Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| US8803784 | 1988-10-31 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI903154A0 FI903154A0 (fi) | 1990-06-21 |
| FI102382B1 true FI102382B1 (fi) | 1998-11-30 |
| FI102382B FI102382B (fi) | 1998-11-30 |
Family
ID=22477194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI903154A FI102382B (fi) | 1987-12-23 | 1990-06-21 | Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykopro teiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoprotei ineja varten |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5194595A (fi) |
| EP (1) | EP0396563B1 (fi) |
| JP (1) | JP2716503B2 (fi) |
| KR (1) | KR0137963B1 (fi) |
| AT (1) | ATE85622T1 (fi) |
| AU (1) | AU617739B2 (fi) |
| CA (1) | CA1320163C (fi) |
| DE (1) | DE3878468T2 (fi) |
| DK (1) | DK173175B1 (fi) |
| FI (1) | FI102382B (fi) |
| HK (1) | HK166295A (fi) |
| MX (1) | MX9203458A (fi) |
| NO (1) | NO300254B1 (fi) |
| WO (1) | WO1989005823A1 (fi) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8914968D0 (en) * | 1989-06-29 | 1989-08-23 | Connaught Lab | Production of virus and purification of viral envelope proteins for vaccine use |
| US6004563A (en) * | 1990-11-07 | 1999-12-21 | American Home Products Corporation | Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same |
| US5824307A (en) * | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
| GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
| GB9207479D0 (en) * | 1992-04-06 | 1992-05-20 | Scotgen Ltd | Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man |
| TW275632B (fi) * | 1992-04-21 | 1996-05-11 | American Cyanamid Co | |
| AU5955294A (en) * | 1993-01-08 | 1994-08-15 | Upjohn Company, The | Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein |
| DK0705109T4 (da) * | 1993-05-25 | 2004-05-10 | Wyeth Corp | Adjuvanser til vacciner mod respiratorisk syncytialvirus |
| EP0744027B1 (en) * | 1994-01-14 | 2005-03-16 | Rath, Matthias, Dr. med. | Use of methods for identifying hydrophilic signal oligopeptides |
| US7300918B2 (en) | 1994-01-14 | 2007-11-27 | Matthias Rath | Method of producing vaccines from protein signal oligopeptides |
| FR2718452B1 (fr) | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
| WO1996010400A1 (en) * | 1994-09-30 | 1996-04-11 | The Uab Research Foundation | Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
| US5716821A (en) * | 1994-09-30 | 1998-02-10 | Uab Research Foundation | Prevention and treatment of respiratory tract disease |
| FR2726472B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin |
| DE4442114A1 (de) * | 1994-11-25 | 1996-05-30 | Buna Sow Leuna Olefinverb Gmbh | Nitrit-, phosphat- und aminfreies Kühl- und Wärmeübertragungsmittel |
| US5811524A (en) * | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| US6015664A (en) * | 1995-11-03 | 2000-01-18 | Mcw Research Foundation | Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B |
| WO1998018819A1 (en) * | 1996-10-29 | 1998-05-07 | Smithkline Beecham Biologicals S.A. | Purification of respiratory syncytial virus antigens |
| US20070067859A1 (en) * | 1997-07-14 | 2007-03-22 | Michel Georges | Double-muscling in mammals |
| US6103466A (en) * | 1997-07-14 | 2000-08-15 | University Of Liege | Double-muscling in mammals |
| DE69841139D1 (de) | 1997-07-14 | 2009-10-22 | Univ Liege | Mutationen im myostatingen steigern muskelmasse in säugetieren |
| US6699478B1 (en) * | 1997-09-19 | 2004-03-02 | Wyeth Holdings Corporation | Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus |
| GB9909077D0 (en) | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
| ATE474854T1 (de) * | 2000-01-27 | 2010-08-15 | Medimmune Llc | Rsv neutralisierende antikörper mit sehr hohen affinität |
| CA2401652A1 (en) | 2000-03-01 | 2001-09-07 | Medimmune, Inc. | High potency recombinant antibodies and method for producing them |
| US6855493B2 (en) | 2000-11-28 | 2005-02-15 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US7179900B2 (en) * | 2000-11-28 | 2007-02-20 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
| AU2005247091B2 (en) * | 2004-05-24 | 2010-08-12 | Polymun Scientific Immunbiologische Forschung Gmbh | Superloaded liposomes for drug delivery |
| EP1812068A4 (en) * | 2004-10-29 | 2010-06-09 | Medimmune Inc | METHODS FOR PREVENTING AND TREATING RSV INFECTIONS AND ASSOCIATED DISEASES |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| EP3109258B1 (en) | 2007-12-24 | 2019-01-23 | ID Biomedical Corporation of Quebec | Recombinant rsv antigens |
| AU2009270399A1 (en) * | 2008-07-18 | 2010-01-21 | Id Biomedical Corporation Of Quebec | Chimeric respiratory syncytial virus polypeptide antigens |
| DK2445526T3 (en) | 2009-06-24 | 2016-06-27 | Glaxosmithkline Biologicals Sa | Recombinant RSV antigens. |
| US20120164176A1 (en) | 2009-07-15 | 2012-06-28 | Kurt Swanson | Rsv f protein compositions amd methods for making same |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| KR102435054B1 (ko) | 2012-08-01 | 2022-08-22 | 버베리안 노딕 에이/에스 | 재조합 변형된 백시니아 바이러스 앙카라(ankara) (mva) 호흡기 신시티알 바이러스(rsv) 백신 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855224A (en) * | 1984-03-09 | 1989-08-08 | Genentech, Inc. | Molecularly cloned diagnostic product and method of use |
| DE3689622T2 (de) * | 1986-01-14 | 1994-06-16 | Univ North Carolina | Impfstoffe gegen menschliche respiratorische viren. |
| US5223254A (en) * | 1987-09-29 | 1993-06-29 | Praxis Biologics, Inc. | Respiratory syncytial virus: vaccines |
| US5001230A (en) * | 1988-02-18 | 1991-03-19 | Schering Corporation | T cell activation markers |
| SG106639A1 (en) * | 2000-10-10 | 2004-10-29 | Gen Electric | Apparatus and method for introducing small amounts of refractory elements into a vapor deposition coating |
-
1988
- 1988-10-31 AU AU27850/89A patent/AU617739B2/en not_active Expired
- 1988-10-31 MX MX9203458A patent/MX9203458A/es unknown
- 1988-10-31 EP EP88909879A patent/EP0396563B1/en not_active Expired - Lifetime
- 1988-10-31 AT AT88909879T patent/ATE85622T1/de not_active IP Right Cessation
- 1988-10-31 KR KR1019890701589A patent/KR0137963B1/ko not_active IP Right Cessation
- 1988-10-31 WO PCT/US1988/003784 patent/WO1989005823A1/en active IP Right Grant
- 1988-10-31 US US07/543,780 patent/US5194595A/en not_active Expired - Lifetime
- 1988-10-31 DE DE8888909879T patent/DE3878468T2/de not_active Expired - Lifetime
- 1988-10-31 JP JP63509171A patent/JP2716503B2/ja not_active Expired - Lifetime
- 1988-11-07 CA CA000582378A patent/CA1320163C/en not_active Expired - Lifetime
-
1990
- 1990-06-21 FI FI903154A patent/FI102382B/fi not_active IP Right Cessation
- 1990-06-22 DK DK199001532A patent/DK173175B1/da not_active IP Right Cessation
- 1990-06-22 NO NO902802A patent/NO300254B1/no not_active IP Right Cessation
-
1992
- 1992-11-20 US US07/979,505 patent/US5288630A/en not_active Expired - Lifetime
-
1995
- 1995-10-26 HK HK166295A patent/HK166295A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2716503B2 (ja) | 1998-02-18 |
| CA1320163C (en) | 1993-07-13 |
| EP0396563A1 (en) | 1990-11-14 |
| EP0396563B1 (en) | 1993-02-10 |
| NO902802D0 (no) | 1990-06-22 |
| AU2785089A (en) | 1989-07-19 |
| DK173175B1 (da) | 2000-03-06 |
| DK153290D0 (da) | 1990-06-22 |
| FI903154A0 (fi) | 1990-06-21 |
| FI102382B (fi) | 1998-11-30 |
| NO902802L (no) | 1990-06-22 |
| MX9203458A (es) | 1992-09-01 |
| DK153290A (da) | 1990-08-16 |
| AU617739B2 (en) | 1991-12-05 |
| DE3878468D1 (de) | 1993-03-25 |
| US5194595A (en) | 1993-03-16 |
| NO300254B1 (no) | 1997-05-05 |
| WO1989005823A1 (en) | 1989-06-29 |
| ATE85622T1 (de) | 1993-02-15 |
| DE3878468T2 (de) | 1993-06-09 |
| HK166295A (en) | 1995-11-03 |
| JPH03501723A (ja) | 1991-04-18 |
| KR0137963B1 (ko) | 1998-04-30 |
| US5288630A (en) | 1994-02-22 |
| KR900700508A (ko) | 1990-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI102382B1 (fi) | Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten | |
| KR970009347B1 (en) | Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 | |
| ATE163682T1 (de) | Respiratorisches syncytiales virus, impstoffe | |
| EE9900343A (et) | Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon | |
| EP0855918A4 (en) | INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF | |
| ES500567A0 (es) | Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. | |
| FI101632B1 (fi) | Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä | |
| HK51597A (en) | Vaccines for human respiratory virus | |
| KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
| DE69836520D1 (de) | Clostridium perfringens Impfstoff | |
| ATE73349T1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
| MY101874A (en) | Vaccine | |
| ZA859428B (en) | Biological preparations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Name/ company changed in application |
Owner name: PHARMACIA & UPJOHN COMPANY |
|
| FG | Patent granted |
Owner name: PHARMACIA & UPJOHN COMPANY |
|
| MA | Patent expired |